Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Irving

Showing results (111-120 of 195) with videos related to

Pageof 20
Sort By:
Alimentary Pharmacology & Therapeutics|June 8, 2020
Therapeutic thresholds for golimumab serum concentrations during induction and maintenance therapy in ulcerative colitis: results from the GO-LEVEL studyMark A Samaan, Georgina Cunningham, Aravind Gokul Tamilarasan, et al.
Crohn'S & Colitis 360|July 11, 2026
Mirikizumab is equally effective in ustekinumab-exposed and ustekinumab-naïve patients with UC: a multicenter real-world cohortMohmmed Tauseef Sharip, Dharmaraj Durai, Eva Vayreda, et al.
United European Gastroenterology Journal|June 8, 2017
Thioguanine in inflammatory bowel disease: Long-term efficacy and safetyMark G Ward, Kamal V Patel, Viraj C Kariyawasam, et al.
Inflammatory Bowel Diseases|March 4, 2026
Mirikizumab four-year sustained and durable efficacy and safety in ulcerative colitis: Final findings from the LUCENT-3 open-label extension studyBruce E Sands, David B Clemow, Geert D'Haens, et al.
Gastroenterology|June 20, 2017
A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled TrialHeidi Maria Staudacher, Miranda C E Lomer, Freda M Farquharson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 29, 2011
Cutting Edge: Regulator of G protein signaling-1 selectively regulates gut T cell trafficking and colitic potentialDeena L Gibbons, Lucie Abeler-Dörner, Tim Raine, et al.
Gut|January 13, 2022
Establishment of a validated central reading system for ileocolonoscopy in an academic settingTim Raine, Holly Pavey, Wendi Qian, et al.
Neurogastroenterology and Motility|August 25, 2021
Long-term personalized low FODMAP diet improves symptoms and maintains luminal Bifidobacteria abundance in irritable bowel syndromeHeidi M Staudacher, Megan Rossi, Thomas Kaminski, et al.
BMJ Open Gastroenterology|September 1, 2025
Etrasimod for the symptomatic relief of ulcerative colitis: a post-hoc analysis from the ELEVATE UC clinical programmeMaría Chaparro, Remo Panaccione, Bruce E Sands, et al.
Frontline Gastroenterology|May 19, 2020
Effectiveness of vedolizumab dose intensification to achieve inflammatory bowel disease control in cases of suboptimal responseMark A Samaan, Siddharth Birdi, Maria Sierra Morales, et al.
Pageof 20

Showing results (111-120 of 195) with videos related to

Sort By:
Pageof 20
Alimentary Pharmacology & Therapeutics|June 8, 2020
Therapeutic thresholds for golimumab serum concentrations during induction and maintenance therapy in ulcerative colitis: results from the GO-LEVEL studyMark A Samaan, Georgina Cunningham, Aravind Gokul Tamilarasan, et al.
Crohn'S & Colitis 360|July 11, 2026
Mirikizumab is equally effective in ustekinumab-exposed and ustekinumab-naïve patients with UC: a multicenter real-world cohortMohmmed Tauseef Sharip, Dharmaraj Durai, Eva Vayreda, et al.
United European Gastroenterology Journal|June 8, 2017
Thioguanine in inflammatory bowel disease: Long-term efficacy and safetyMark G Ward, Kamal V Patel, Viraj C Kariyawasam, et al.
Inflammatory Bowel Diseases|March 4, 2026
Mirikizumab four-year sustained and durable efficacy and safety in ulcerative colitis: Final findings from the LUCENT-3 open-label extension studyBruce E Sands, David B Clemow, Geert D'Haens, et al.
Gastroenterology|June 20, 2017
A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled TrialHeidi Maria Staudacher, Miranda C E Lomer, Freda M Farquharson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 29, 2011
Cutting Edge: Regulator of G protein signaling-1 selectively regulates gut T cell trafficking and colitic potentialDeena L Gibbons, Lucie Abeler-Dörner, Tim Raine, et al.
Gut|January 13, 2022
Establishment of a validated central reading system for ileocolonoscopy in an academic settingTim Raine, Holly Pavey, Wendi Qian, et al.
Neurogastroenterology and Motility|August 25, 2021
Long-term personalized low FODMAP diet improves symptoms and maintains luminal Bifidobacteria abundance in irritable bowel syndromeHeidi M Staudacher, Megan Rossi, Thomas Kaminski, et al.
BMJ Open Gastroenterology|September 1, 2025
Etrasimod for the symptomatic relief of ulcerative colitis: a post-hoc analysis from the ELEVATE UC clinical programmeMaría Chaparro, Remo Panaccione, Bruce E Sands, et al.
Frontline Gastroenterology|May 19, 2020
Effectiveness of vedolizumab dose intensification to achieve inflammatory bowel disease control in cases of suboptimal responseMark A Samaan, Siddharth Birdi, Maria Sierra Morales, et al.
Pageof 20